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Growth hormone secretagogue receptor 1α (GHSR1a) and Orexin 1 receptor (OX1R)
are involved in various important physiological processes, and have many similar
characteristics in function and distribution in peripheral tissues and the central nervous
system. We explored the possibility of heterodimerization between GHSR1a and OX1R
and revealed a signal transduction pathway mechanism. In this study, bioluminescence
and fluorescence resonance energy transfer and co-immunoprecipitation (Co-IP)
analyses were performed to demonstrate the formation of functional GHSR1a/OX1R
heterodimers. This showed that a peptide corresponding to the 5-transmembrane
domain of OX1R impaired heterodimer construction. We found that ghrelin stimulated
GHSR1a/OX1R heterodimer cells to increase the activation of Gαs protein, compared
to the cells that express GHSR1a. Stimulation of GHSR1a/OX1R heterodimers with
orexin-A did not alter GPCR interactions with Gα protein subunits. GHSR1a/OX1R
heterodimers induced Gαs and downstream signaling pathway activity, including
increase of cAMP-response element luciferase reporter activity and cAMP levels. In
addition, ghrelin induced a higher proliferation rate in SH-SY5Y cells than in controls.
This suggests that ghrelin GHSR1a/OX1R heterodimers promotes an upregulation of
a Gαs-cAMP-cAMP-responsive element signaling pathway in vitro and an increase in
neuroblastoma cell proliferation.
Keywords: growth hormone secretagogue receptor 1α (GHSR1a), orexin type 1 receptor (OX1R),
heterodimerization, allosteric signaling, neuroblastoma cell proliferation
INTRODUCTION
Ghrelin, a 28-amino acid peptide, is the first endogenous ligand for GHSR1a. GHSR1a couples
to Gαq resulting in activation of phospholipase C (PLC), inositol trisphosphate (IP3), and
mobilization of Ca2+ (Holst et al., 2004). Apart from the pituitary gland, GHSR1a is distributed
in the central nervous system (CNS) widely, especially in hypothalamic regions (Howick et al.,
2017; Medrano et al., 2017). GHSR1a is also expressed in the heart, pancreas, intestine, kidney,
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adipose tissue, and the male and female reproductive systems.
GHSR1a is important in many processes, including stress, reward
and feeding behavior. Recent data have revealed the dimerization
of various receptors, indicating their ability to interact with
GHSR1a in signal regulation, changes in the signal cascade, and
changes in the trafficking and internalization of both protomers
of the dimer complex (Howick et al., 2017). Furthermore, the
data show that GHSR1a and other receptors, including dopamine
1 receptor (D1R), dopamine 2 receptor (D2R) (Kern et al.,
2012), melanocortin-3 receptor (MC3R) (Rediger et al., 2011),
serotonin 2C receptor (5-HT2C) (Schellekens et al., 2015), and
cannabinoid type 1 receptor (CB1) (Kola et al., 2005), can
dimerize with GHSR1a. After dimerization, these receptor dimers
modify, assemble, and block existing signaling pathways, leading
to different physiological functions; thus, the dimerized growth
hormone secretagogue system appears to play an important and
complex role (Wellman and Abizaid, 2015).
Orexin-A and Orexin-B are neuropeptides secreted by
neurons (Sakurai et al., 1998). They bind to orexin receptor 1
(OX1R) and 2 (OX2R). Orexin-A binds OX1R preferentially. It
can also bind to OX2R. However, orexin B binds OX2R only. The
OX1R is a Gαq protein-coupled receptor that classically induces
PLC activation and subsequent cellular calcium transients. OX1R
also stimulates cAMP synthesis in primary rat astrocyte culture
(Woldan-Tambor et al., 2011). OX2R is primarily associated with
the Gαq, Gαi and Gαs subtypes (Tang et al., 2008; Chen et al.,
2015; Bai et al., 2017). Orexin receptors are widely expressed in
the CNS where orexin neuron terminals are located. Recently,
orexin neurons were found to play an essential part in regulating
various behavioral and physiological responses mediated by the
hypothalamus, such as in circadian rhythms (Gooley et al., 2006;
Chen et al., 2015), anxiety, cardiorespiratory function (Mcdowall
et al., 2006), feeding (Inutsuka et al., 2014), and reward (Gutierrez
et al., 2011). GPCRs form heterodimers as well as homodimers.
Human OX1R has been found to homodimerize and interact
with other receptors functionally. For example, GPR103 and
OX1R heterodimerize, as do OX1R and kappa opioid receptors
(κOR) (Chen et al., 2015; Davies et al., 2015; Bai et al., 2017).
GPCR heterodimers can exhibit novel function or elevate its
own activity. Heterodimerization is important for their response
and trafficking, and many important physiological processes take
place through the interactions of these receptors.
GPCRs play an essential role in cell communication. Although
they form functional monomers, there is growing evidence that
GPCR dimerization plays a key role in the cooperation of cell
signal integration (Chen et al., 2015). GHSR1a and OX1R are
involved in stress, reward and feeding behavior. This supports
the scientific hypothesis that dimerization of GHSR1a/OX1R may
change their original functions, which readjust their reaction
to ghrelin and play an important role in the ghrelin system
and hypothalamus. Our study aimed to detect this possibility
and survey a heterodimerization-mediated signal transduction
Abbreviations: BRET, bioluminescence resonance energy transfer; EYFP,
enhanced yellow fluorescent protein; FRET, Förster resonance energy transfer;
GHSR1a, growth hormone secretagogue receptor 1α; GPCRs, G-protein-coupled
receptors; HEK, human embryonic kidney; OX1R, orexin type 1 receptor; Rluc,
Renilla luciferase.
mechanism. We also explored whether this type of signal
transduction is involved in the proliferation of neuroblastoma
cells.
EXPERIMENTAL PROCEDURES
Plasmids, Reagents, Antibodies
The mammalian expression vector pcDNA3.1(+) was purchased
from Invitrogen Life Technologies (Paisley, United Kingdom).
The plasmids pcDNA3.1-OX1R, which contain human OX1R
cDNA, and pcDNA3.1-GHSR1a, which contains GHSR1a,
were obtained from the cDNA Resource Centre (Bloomsburg
University, Bloomsburg, PA, United States). pEYFP-N1,
containing EYFP, and pRluc-N1, containing the Rluc plasmid,
were provided by Clontech and PerkinElmer, Inc. SRE-luc,
CRE-luc and NFAT-RE-luc were obtained from Promega
(Madison, WI, United States).
Human ghrelin and orexin-A were purchased from Phoenix
Pharmaceuticals (Belmont, CA, United States). HEPES-buffered
phenol red-free medium, DMEM (Dulbecco’s Modified Eagle
Medium) and RPMI-1640 culture medium were purchased from
Gibco, (Gibco, Invitrogen, Paisley, United Kingdom). Forskolin
(FSK) was purchased from Sigma-Aldrich Shanghai Trading Co.
Ltd. (Shanghai, China). Anti-Myc, Anti-HA, Anti-GHSR1a and
anti-OX1R antibodies were obtained from Novus Biologicals
(Abingdon, United Kingdom). Anti-HA-agarose was purchased
from Pierce Chemical Co.
Construction of Expression Vectors
GHSR1a-EYFP, CRH1R-ECFP and OX1R-ECFP, which
respectively encode an ECFP-tag and EYFP-tag were constructed.
Enhanced cyan fluorescent protein (ECFP) and EYFP were
attached to the C-termini of OX1R and GHSR1a by inserting
the ORFs of OX1R, CRH1R and GHSR1a into the ECFP-N1
and EYFP-N1 vectors, respectively, resulting in OX1R-ECFP,
CRH1R-ECFP and GHSR1a-EYFP. Insertion was confirmed
by enzyme digestion and sequencing. Gαi2-Rluc8, Gαq-Rluc8,
Gαs-Rluc8, Myc-GHSR1a and HA-OX1R were constructed as
described previously (Chen et al., 2015), to generate Myc-tagged
GHSR1a or HA-OX1R, sequences encoding the Myc epitope
tag (EQKLISEEDL). The HA epitope tags (YPYDVPDYA) were
PCR-inserted at the N-terminus of GHSR1a or OX1R. Fusing
either the N-terminal fragment of Venus (Venus N: amino
acids 1–172) or the C-terminal fragment of Venus (Venus C:
amino acids 156–239) was used to produce GHSR1a-VN173 and
OX1R-VC155. OX1R-Rluc and CRH1R-Rluc were constructed
as described; all of these constructs encode a C-terminal Rluc tag.
All reconstructed plasmids were verified by commercial DNA
sequencing.
Cell Culture and Transfection
The HEK293 and SH-SY5Y cell lines were cultured in
DMEM culture medium at 37◦C in 5% CO2. When the cell
fusion density was approximately 80% (cell fusion during
transfection varied during different experiments), cells were
transfected using Lipofectamine 2000. After transfection for
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6 h, the serum-containing medium was replaced, and cells
were cultured for 24 h. Plasmid expression was observed
via fluorescence microscopy. Empty vectors were added to
normalize the final plasmid amount. HEK293 cells were
transfected with pcDNA3.1-OX1R, pcDNA3.1-GHSR1a and
pcDNA3.1-OX1R/pcDNA3.1-GHSR1a to obtain the next
generation of cells stably expressing GHSR1a, OX1R and
GHSR1a/OX1R. Screening was performed in 24-well plates
with G418 (0.5 mg/mL) (Gibco, Invitrogen, United Kingdom)
for 10 weeks. Receptor expression was assessed by performing
Western blotting.
Confocal Microscopy
HEK293 cells were transfected with GHSR1a-EYFP and
OX1R-ECFP plasmids. The cells were transferred to glass cover
slips in 6-well plates after 24 h. The glass cover slips previously
underwent high-pressure sterilization and were treated with
Poly-D-lysine at 0.05 mg/mL for 3 h, followed by washing 3 times
with PBS. After culture for 24 h at 37◦C, the cells were washed
with PBS for 3 times and were then fixed for 5 min. The cells
were washed with PBS 3 times (5 min each). A Leica DMRE
laser scanning confocal microscope (Leica, Milton Keynes,
United Kingdom) was used to detect fluorescence as previously
described (Chen et al., 2015; Bai et al., 2017).
BRET Assay
To monitor constitutive GHSR1a and OX1R interactions,
OX1R-Rluc and GHSR1a-EYFP plasmids were transfected into
HEK293 cells at ratios of 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, and 1:8
to express donor protein with increasing amounts of acceptor
protein. At 24 h post-transfection, cells were trypsinized and
cultured on microplate for another 24 h. Coelenterazine h (5 µM;
Promega) was added for BRET measurements with an Rluc filter
(480 nm) and an EYFP filter (550 nm). To monitor the induced
interactions between GHSR1a and OX1R, BRET signals were
measured, with slight modifications. Lastly, cells were transfected
with OX1R-Rluc and/or GHSR1a-EYFP and stimulated with an
agonist (ghrelin or orexin-A). The experimental assay method
was carried out as previously described (Chen et al., 2015) using
the BRET saturation assay. HEK293 cells were co-transfected
with a constant amount of the OX1R-Rluc construct, each at
0.15 µg/well, and increasing amounts of the EYFP construct
(0.15–1.2 µg/well). Calculated BRET ratios were plotted relative
to total fluorescence/luminescence ratios, and the data were
analyzed by non-linear regression curve fitting (one site–specific
binding) using GraphPad Prism software.
FRET Assay
Fluorescence resonance energy transfer (FRET) assays were
performed as described previously (Ma et al., 2007; Cai
et al., 2017). The EYFP-GHSR1a and ECFP-OX1R plasmids
were co-transfected into HEK293 cells as the FRET system.
In addition, donor ECFP-OX1R and acceptor EYFP, ECFP
and EYFP-GHSR1a, or ECFP-CRH1R and EYFP-GHSR1a were
co-transfected as negative controls. FRET signals were detected
using a FLUOstar OPTIMA microplate reader (BMG Labtech,
Germany) after 20 h. The calculation method and equation used
are described previously (Chen et al., 2015; Bai et al., 2017).
Calculation of FRET efficiency: After 12–24 h, FRET signals
were detected using the FRET Kit for the Leica AM TIRF MC
system (Leica Microsystems). For each experiment, at least 10
live cells were analyzed for each condition (donor ECFP-OX1R
or acceptor EYFP-GHSR1aor ECFP-OX1R and EYFP-GHSR1a).
The efficiency of FRET (EA (i)) was calculated using the following
equation:
EA(i) =B-A× β− C× (γ− α× β)
C× (1− β× δ)
Where A, B, and C correspond to the intensities of the three
signals (donor, FRET, and acceptor, respectively), and α, β, γ,
and δ are the calibration factors generated by the acceptor- and
donor-only references.
Co-immunoprecipitation (Co-IP) and
Immunoblotting
Co-immunoprecipitation was performed as previously described
(Wang et al., 2014). The HA-OX1R and Myc-GHSR1a plasmids
were co-transfected into HEK293. After 36 h, the medium was
discarded, and the HEK293 cells were washed with 1 mL of
precooled PBS for twice and centrifuged at 3000 r/min for
3 min. The cells were collected and 200 µL of weak lysate
buffer was added (RIPA including PMSF) for cracking at 4◦C.
The supernatant was removed after centrifuging at 16,000 g for
30 min. Then, 100 µL of supernatant and 20 µL of anti-HA
agarose beads were mixed with gentle rotation for 4 h at 4◦C. The
mixture was centrifuged at 16,000 g for 10 s, and the precipitate
was washed 4 times with cell lysis buffer. Finally, the proteins
were analyzed by Western blotting.
Western Blotting
Cells were lysed and separated by 10% SDS-PAGE followed by
transfer to PVDF membranes. The proteins of interest were
probed with primary and secondary antibodies as described
above. Enhanced chemiluminescence (ECL) kits were used to
visualize and analyze protein bands. Films were scanned and
bands were analyzed using a ChemiDoc MP Imaging System
(Bio-Rad).
Design and Synthesis of TM Peptides
The inserted peptides were confirmed to have the correct
orientation because HIV TAT binds to phosphatidylinositol-
(4, 5)-bisphosphate on the inner surface of the membrane
(Bai et al., 2017). An HIV transactivator of transcription
(HIV TAT)-linked peptide (YGRKKRRQRRR) was fused
to the C-termini of the OX1R TM1 (47-67 position of
amino acid), TM5 (214-235 position of amino acid) and
TM7 (337-360 position of amino acid). Primary amino acid
sequences of the peptides are the following: TM1, PAIYML
VFLLGTTGNGLVLWTVFYGRKKRRQRRR; TM5, VSSTTV
GFVVPFTIMLTCYFFIAYGRKKRRQRRR; and TM7, LMNIFP
YCTCISYVNSCLNPFLYYGRKKRRQRRR. The identity of the
TM peptide sequences was confirmed by performing liquid
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chromatography (LC)-MS (Shimadzu2020 and Water1010).
The molecular weights of TM1, 5, and 7 were 4067.95, 4209.11,
and 4355.05 Da, respectively. HEK293 cells were co-transfected
with OX1R-Rluc and GHSR1a-EYFP (1:3) and incubated with
interference peptides corresponding to TM1 or TM5, or TM7
(4 µM) at 37◦C, and BRET was detected as described above to
measure the effects of interference peptides on GHSR1a/OX1R
dimers.
NFAT-RE, CRE and SRE Luciferase
Reporter Assay
We detected the activity of NFAT-RE (nuclear factor of activated
T-cells-response element), CRE (cAMP-response element)
and SRE (serum response element) in HEK293-OX1R,
HEK293-GHSR1a, and HEK293-GHSR1a/OX1R stable
expression cells to study the effects of GHSR1a/OX1R
heterodimers on downstream signaling. We selected three
types of downstream signaling factors, specifically - NFAT-RE,
CRE and SRE, which detect OX1R, GHSR1a or GHSR1a/OX1R
binding to the three G protein subtypes Gαq, Gαs, and Gαi,
respectively. These are useful for analyzing the effects of
intracellular signal transduction pathways after GHSR1a/OX1R
heterodimer formation. To perform NFAT-RE, CRE, and SRE
luciferase reporter assay, the cells stably expressing GHSR1a,
OX1R, or GHSR1a/OX1R were transfected with pNFAT-Luc,
pCRE-Luc, or pSRE-Luc, together with pRL-Tk. The cells were
starved and stimulated with orexin-A or ghrelin at 100 nM for
6 h prior to harvest at 24 h after transfection. These experiments
were performed as described previously (Chen et al., 2015; Bai
et al., 2017).
Measurement of Intracellular cAMP
ELISA Assay for cAMP
HEK293-GHSR1a, HEK293-OX1R, and HEK293-
GHSR1a/OX1R stable cell lines were cultured in 24-well
cell culture plates (1–2 × 106). cAMP levels were measured with
a cAMP ELISA kit (Cell Biolabs, Inc., United States). The assay
methods were performed as described previously (Chen et al.,
2015; Liu et al., 2016).
BRET EPAC Biosensor for cAMP Monitoring
We also used the YFP-Epac-RLuc plasmid to measure
intracellular cAMP levels (Ji et al., 2017). YFP-Epac-RLuc
was transfected into HEK293-GHSR1a, HEK293-OX1R and
HEK293-GHSR1a/ OX1R cells. The cells were collected and
distributed in a 96-well white microplate after 24 h and cultured
in HEPES-buffered phenol red-free medium for another 24 h.
Cells were washed with PBS and resuspended with Dulbecco’s
phosphate buffered saline (D-PBS). BRET was measured
at room temperature. Cells were stimulated with agonists
(ghrelin 100 nM and/or orexin-A, 100 nM) for 5 min. BRET
readings were collected by Tristar LB941 plate reader (Berthold
technologies GmbH & Co., Germany).
Intracellular Calcium Analysis
The stable cell lines HEK293-GHSR1a, HEK293-OX1R, and
HEK293-GHSR1a/OX1R were plated at 5 × 104 cells/well in
96-well microplates and cultured for 24 h. A Fluo-4 NW assay
kit (Invitrogen, United States) was used as per the instructions.
The solution was added to cells and incubated at 37◦C for
30 min and then at 20◦C for an additional 30 min (Chen et al.,
2015). HEK293 cells were treated with ghrelin (100 nM) and/or
orexin-A (100 nM). Fluorescence was measured with Tristar
LB941 plate reader at an emission wavelength of 515 nm and
excitation wavelength of 485 nm. The calcium ratio was measured
by using the fluorescence value after adding the agonist taking
away fluorescence value before adding agonist divided by the
fluorescence value before adding the agonist.
Gα Protein Subunit Assay
HEK-293 cells were cultured and when the cells reached
∼75% confluence, plasmids encoding EYFP (GHSR1a-EYFP,
OX1R-EYFP and GHSR1a-VN173/OX1R-VC155) and Rluc
(Gαs-Rluc8, Gαi2-Rluc8, and Gαq-Rluc8) fusion proteins were
co-transfected. Gαs-Rluc8 or Gαq-Rluc8 or Gαi2-Rluc8 and
GHSR1a-VN173 or OX1R-VC155A were also used for the
negative controls. Then, cells were cultured in white 96-well
cell culture plates with Poly-D-lysine-coated (fill multiwall plates
with the working solution [1:19 water] and incubated for 1 h in
a 37◦C incubator. The solution was then removed by vacuum
aspiration and allowed to surface dry. After 24 h, agonists ghrelin
(100 nM) and/or orexin-A (100 nM) were added, and the cells
were stimulated for 20 min. The BIFC-BRET ratio was measured
in the presence of Coelenterazine h (5 µM).
Kinetics of the GHSR1a/OX1R
Heterodimer by BIFC-BRET
HEK293 cells were transfected with Rluc8-tagged
(β-arrestin1-Rluc8 and β-arrestin2-Rluc8) and Venus-tagged
(GHSR1a-VN173/OX1R -VC155) constructs. Two negative
controls (β-arrestin1-Rluc8 or β-arrestin2-Rluc8 and
GHSR1a-VN173, β-arrestin1-Rluc8 or β-arrestin2-Rluc8 and
OX1R-VC155A) were also introduced. The cells were transferred
to white 96-well cell (cell passage density: 5 × 104/well culture
plates with Poly-D-lysine-coated after 24 h. Then, the cells were
cultured in HEPES-buffered phenol red-free medium. After 24 h,
agonists ghrelin (100 nM) and/or orexin-A (100 nM) were added
and stimulated for 20 min. The BRET ratio was measured in the
presence of 5 µM Coelenterazine h. BIFC-BRET was monitored
by extended BRET for 10 min to generate kinetic curves.
Following the addition of orexin-A and/or ghrelin (100 nM) (Bai
et al., 2017), monitoring was continued for an additional 50 min.
Cell Proliferation Assay
Human SH-SY5Y-GHSR1a/OX1R stable cells were cultured in a
96-well plate (cell density: 4–5× 104/well). After 24 h, these cells
were performed with 1, 10, and 100 nM ghrelin for another 24 h.
Cell proliferation was measured using a CCK-8 (Dojindo, Japan)
viability assay (Ji et al., 2017). The stable SH-SY5Y-GHSR1a,
SH-SY5Y-OX1R, and SH-SY5Y-GHSR1a/OX1R cells were seeded
in 96-well plates. After 24 h, all the cells were stimulated with
ghrelin (100 nM) and/or orexin-A (100 nM) for 24 h. The CCK-8
assay was performed according to manufacturer’s instructions.
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Absorbance was measured at 450 nm after incubation. Each
sample was repeated five times.
Statistical Analysis
The data were analysed using Graph Pad Prism 6.0. All data
are shown as the mean ± SEM. One-way ANOVA was used for
multiple group comparisons and random single factor analysis
of variance using SPSS 11.5 software. Additionally, t-tests were
performed, and statistical significance was set at P ≤ 0.05.
The statistical analyses were performed with SPSS (version
19.0) and the repeated measurement data were analyzed by
two-way ANOVA (Repeated Measures). Statistical parameters
(one-way (Figures 5A–C, 6B,C, 7A,B) or repeated measures
(Figures 6D, 8A,D) ANOVA) were used, and, when appropriate,
with Bonferroni (comparison between all or selected groups) post
hoc tests.
RESULTS
Co-localization of GHSR1 and OX1R Was
Detected Using Laser Confocal
Microscopy
To identify co-localization of GHSR1a and OX1R in HEK293
cells, analysis of cells expressing C-terminal EYFP-tagged
GHSR1a and ECFP-tagged OX1R was performed by laser
confocal microscopy, the image results confirmed that GHSR1a
and OX1R co-localized on membranes of HEK293 cells
(Figure 1). The fact the cells could coexpress GHSR1a and
OX1R on their membranes suggests that the two receptors might
interact on the cell membranes
BRET Detected Heterodimerization
Between GHSR1a/OX1R
To determine whether GHSR1a/OX1R can form a heterodimer,
a BRET test based on luminescence and fluorescence detection
was performed. In this experiment, the energy donor (Rluc
fusion protein) and energy receptor (EYFP fusion protein)
transfection ratio was 1:3. As shown in Figure 2A, the mBRET
ratio of OX1R-Rluc to GHSR1a-EYFP (190 ± 0.010) was lower
than that of the positive control group OX1R–Rlu/κOR-EYFP
(Chen et al., 2015) (mBRET ratio 195 ± 0.030), but there
was not a significant difference between the two, and the
mBRET ratio was higher than that of the negative control group
(CRH1R-Rluc/GHSR1a-EYFP) (Navarro et al., 2015) (mBRET
ratio: 37.5± 0.010), with a significant difference between the two.
Cells expressing GHSR1a-EYFP with Rluc or OX1R-Rluc with
EYFP were also used as a negative control. The results showed
that BRET could occur between the GHSR1a/OX1R in cells.
These results suggest that heterodimerization of GHSR1a/OX1R
may not require ligand binding.
BRET was also used to determine whether ligands of
OX1R/GHSR1a induce heterodimerization. As shown in
Figure 2B, the OX1R/GHSR1a dimer is a constitutive dimer, but
ghrelin or orexin-A enhanced the interaction between OX1R and
GHSR1a such that their addition caused the formation of many
additional dimers.
To investigate the heterodimerization of GHSR1a/OX1R,
BRET saturation assay was used to detect their interactions
in HEK293 cells. Living Cells were co-transfected with
increasing amounts of acceptor (GHSR1a-EYFP or EYFP)
and constant amount of the donor (OX1R-Rluc, CRH1R-Rluc
or Rluc). As shown in Figure 2C, the BRET ratio between
GHSR1a-EYFP and OX1R-Rluc increased with the increasing
amounts of acceptor expression of GHSR1a-EYFP, until a
plateau was reached (Figure 2C). However, in the negative
control group, CRH1R-Rluc and GHSR1a-EYFP, increasing
expression of GHSR1a-EYFP resulted in a low ratio. This
suggests a non-specific linear relationship between them. This
is consistent with a previous report that BRET signals are low
when OX1R-Rluc and GHSR1a-EYFP are co-transfected. These
results indicate that OX1R-Rluc and GHSR1a-eGFP can form
heterodimers (Navarro et al., 2015; Bai et al., 2017).
FRET Assay
Fluorescence resonance energy transfer was used to analyze the
interaction between GHSR1a/OX1R. In these experiments,
HEK293 cells were transfected with (a) CRH1R-ECFP
and GHSR1a-EYFP, (b) GHSR1a-EYFP, (c) OX1R-ECFP,
or (d) OX1R-ECFP and GHSR1a-EYFP. In these images,
interaction sites are marked yellow (Figure 3A). In individually
transfected cells and control cells containing GHSR1a-EYFP
and CRH1R-ECFP, lower FRET signals were observed.
However, a FRET signal was detected doubly co-transfected
with GHSR1a-EYFP and OX1R-ECFP, further indicating that
GHSR1a/OX1R may form dimers (Figure 3B).
Heterodimerization of GHSR1a/OX1R
Determined by Co-immunoprecipitation
(Co-IP)
Co-immunoprecipitation analysis was used to identify the
interaction between OX1R and GHSR1a in the formation
of a heterodimer. After co-expression in HEK293 cells of
HA-OX1R/Myc-GHSR1a, using anti-Myc antibodies to do
immunoprecipitation resulted in the presence of anti-HA
immunoreactivity. SDS-PAGE demonstrated the presence of
bands identified by the Myc antibody (Figure 4A), consistent
with the monomeric form of HA-OX1R. This result showed
that GHSR1a/OX1R could form heterodimers, when expressed
simultaneously. When Myc-GHSR1a or HA-OX1R were singly
overexpressed or placed in mixed samples, the Co-IP results were
similar to those for the negative control.
TM1, 5, and 7 Provide the GHSR1a/OX1R
Dimer Interface
Transmembrane domains (TMs) are important for the formation
of head-to-head interfaces in class A GPCR dimers (Johnston
et al., 2012; Meng et al., 2014; Cordomi et al., 2015; Xue et al.,
2015). To identify dimerization interfaces among the seven
TM domains of GHSR1a/OX1R, the effects of cell-penetrating
interference peptides containing the sequence of the hydrophobic
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FIGURE 1 | Co-expression and co-localization of GHSR1a and OX1R in HEK293 cells. Analysis of GHSR1a- and OX1R-transfected HEK293 cells using laser
confocal microscopy. OX1R-ECFP (cyan) and GHSR1a-EYFP (yellow) were expressed in HEK293 cells. OX1R and GHSR1a confocal images are merged to show
co-localization regions (green).
FIGURE 2 | Heterodimerization of GHSR1a/OX1R examined with BRET assay in live cells. Heterodimerization of GHSR1a/OX1R was measured by BRET. HEK293
cells were transiently transfected with the donor plasmids and acceptor plasmids. Twenty-four hours after transfection, both the fluorescence and luminescence of
each sample were measured prior to every experiment to confirm equal expression of Rluc while monitoring the increase in Venus expression. (A) BRET ratios were
analyzed and are expressed as the means ± SEM (N = 3) of four experiments. ∗∗∗p < 0.001, OX1R-Rluc+ GHSR1a-EYFP vs. control groups
(CRH1R-Rluc/GHSR1a-EYFP), as a positive control group (OX1R–Rluc/κOR-EYFP). (B) Effects of ghrelin and/or orexin-A on the BRET ratio. HEK293 cells were
co-transfected with OX1R-Rluc and GHSR1a-EYFP plasmids (1:3). After 24 h of transfection, the Rluc substrate Coelenterazine h was added for 5 min, and the cells
were treated with ghrelin (100 nM) and/or orexin-A (100 nM) or vehicle for 10 min, BRET ratios were analyzed and are expressed as the mean ± SEM of four
experiments. ∗p < 0.05 compared with the control group (no treated). (C) BRET saturation assay. HEK293 cells were co-transfected with a constant amount of the
OX1R-Rluc construct, each at 0.15 µg/well, and increasing amounts of the EYFP construct (0.15–1.2 µg/well). Calculated BRET ratios were plotted relative to total
fluorescence/luminescence ratios, and the data were analyzed by non-linear regression curve fitting (one site–specific binding) using GraphPad Prism software.
BRET ratios were analyzed and are expressed as means ± SEM (N = 3) of four experiments.
transmembrane helices on GHSR1a/OX1R heterodimerization
were examined by BRET.
As shown in Figure 4B, TM 5 significantly reduced
GHSR1a/OX1R dimer BRET signals by 50–60%. Thus,
peptides corresponding to TM 5 can disrupt the formation
of GHSR1a/OX1R heterodimers, further suggesting the
involvement of TM 5 at the GHSR1a/OX1R heterodimer
interface. Notably, TM1 and TM7 had little effect on BRET
signals, indicating that these peptides do not induce significant
conformational changes or are less important for GHSR1a/OX1R
dimerization in vitro.
Ghrelin Increases CRE-luc, NFAT-luc and
SRE-luc Activity in
HEK293-GHSR1a/OX1R Cells
To analysis the effect of GHSR1a/OX1R dimers on
downstream signaling, the activity of NFAT-RE, SRE,
and CRE in HEK293-OX1R, HEK293-GHSR1a and
HEK293-GHSR1a/OX1R cells were assessed respectively, as
shown in Figure 5.
In HEK293-GHSR1a cells, the activity of NFAT-RE and CRE
increased significantly with ghrelin exposure (p < 0.01). The
results suggested that GHSR1a coupled to the Gαq and Gαs
subtypes. Interestingly, Gαi-coupled receptors inhibited adenylyl
cyclase (AC), and through the βγ subunits, activated the ERK
pathway via SRE-luc in the HEK293 GHSR1a cells with ghrelin,
the results showed that GHSR1a coupled to the Gαi and
the βγ subunits. The SRE-luc activity of GHSR1a/OX1R cells
treated with orexin A was increased (p < 0.01), compared with
HEK293 OX1R cells. The ghrelin treatment of HEK293 cells
co-expressing both receptors further decreased SRE-luc activity,
compared with HEK293 GHSR1a cells. The intracellular CRE-luc
activity of GHSR1a/OX1R cells treated with ghrelin was increased
(p < 0.01), and treatment of HEK293 GHSR1a/OX1R cells
with orexin-A had no effect on CRE–luc activity. The results
showed that heterodimerization of GHSR1a/OX1R increased
CRE activity when ghrelin was added to HEK293-GHSR1a and
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FIGURE 3 | Förster resonance energy transfer assay to detect the dimerization of GHSR1a/OX1R. (A) FRET imaging of constitutive GHSR1a/OX1R heteromeric
interactions in living cells. HEK293 cells were transiently transfected with plasmids encoding (a) as a negative control group, CRH1R-ECFP and GHSR1a-EYFP. (b)
GHSR1a-EYFP (acceptor), (c) OX1R-ECFP (donor), (d) OX1R-ECFP and GHSR1a-EYFP. Left panels, ECFP; center panels, EYFP; right panels, corrected FRET.
(B) Normalized FRET values, calculated as described in Experimental Procedures. The data represent mean ± SEM (N = 3) of four independent experiments.
Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparison post hoc test. ∗∗∗p < 0.001 vs. the negative groups
CRH1R-ECFP and GHSR1a-EYFP.
FIGURE 4 | The dimerization of GHSR1a/OX1R and effects of interfering peptides on GHSR1a/OX1R heterodimers. (A) HEK293 cells were either not transfected
(mock) or transfected with HA–OX1R, Myc–GHSR1a or both (co-transfection). As negative control, samples containing either HEK293 HA–OX1R cells or HEK293
Myc–GHSR1a cells were mixed (Mix). Cell lysates were immunoprecipitated with anti-HA agarose beads and immunoblotted with anti-Myc antibody (upper panel).
Cell lysates were examined by immunoblotting with either an anti-Myc or anti-HA antibody (lower panels). The data represent means ± SEM (N = 3) of four
independent experiments. (B) HEK293 cells were co-transfected with OX1R-Rluc and GHSR1a-EYFP (1:3) and incubated at 37◦C for 2 h with HIV TAT–fused TM
peptides (10 µM) corresponding to TM1, TM5, or TM7 of OX1R. BRET ratios were analyzed and are expressed as the means ± SEM (N = 3) of four experiments
(one-way analysis of variance; ns, not significant, p > 0.05; ∗∗p < 0.01 vs. control group).
OX1R cells. This which further confirms that the GHSR1a/OX1R
heterodimer promotes the Gαs signaling pathway.
Detection of Intracellular cAMP
To detect whether GHSR1a/OX1R dimerization leads to change
in signaling pathways, intracellular cAMP concentrations were
measured using an ELISA assay kit. First, we compared
cAMP accumulation in HEK-GHSR1a, HEK293-OX1R and
HEK293-GHSR1a/OX1R cells. In the HEK-293 GHSR1a/OX1R
cells with ghrelin stimulation, cAMP levels were higher than
in HEK293 GHSR1a or HEK293-OX1R cells significantly
(Figure 6A). However, when treated with orexin-A, BRET
signals in HEK293-GHSR1a/OX1R cells did not differ from those
in HEK293-OX1R cells (Figure 6B), suggesting that orexin-A
cannot enhance the cAMP level through the GHSR1a/OX1R
heterodimer. The results suggest that GHSR1a/OX1R may
strengthen Gαs coupling, when GHSR1a /OX1R are expressed
with ghrelin stimulation.
To confirm this finding, we also used the cAMP BRET
biosensor method to determine whether the heterodimer
affects cAMP accumulation. The sensor consists of an
N-terminal-truncated variant of EPAC tagged with Rluc
and YFP at the N and C termini, respectively (Barak
et al., 2008; Ji et al., 2017). After binding of the cAMP,
this change in conformation leads to a decrease in BRET
that presumably increases the distance between the donor
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FIGURE 5 | Effects of GHSR1a/OX1R heterodimerization on NFAT, CRE and
SRE activities. Twenty-four hours after transfection with pNFAT-luc (A),
pCRE-luc (B), and pSRE-luc (C) together with pRL-TK, HEK293-GHSR1a,
HEK293-OX1R, and HEK293-GHSR1a/OX1R cells were stimulated with
ghrelin (100 nM) and/or orexin-A (100 nM) for 6 h prior to harvest. Firefly and
Rluc activities were assay using a Dual-Luciferase Reporter Assay System,
and the ratios of firefly to Rluc luminescence were calculated. The data
represent the means ± SEM (N = 3) of at least four independent experiments.
Statistical analysis was performed using one-way ANOVA followed by Tukey’s
multiple comparison post hoc test. ∗∗p < 0.01, cells co-expressing both
GHSR1a and OX1R treated with orexin-A vs. cells expressing OX1R alone;
##p < 0.01, HEK293 cells co-expressing GHSR1a and OX1R treated with
ghrelin vs. cells expressing GHSR1a alone. ns, not significant, p > 0.05.
and acceptor. The reduction in the BRET signal with FSK
is consistent with its role as a stimulator that promotes
cAMP production (Barak et al., 2008). After treatment with
ghrelin, BRET signals were lower in HEK293-GHSR1a/OX1R
cells than in HEK293- GHSR1a and HEK293-OX1R cells
significantly (Figure 6B). However, after treatment with
orexin-A, BRET signals in HEK293-GHSR1a/OX1R cells did
not differ from those in HEK293-OX1R cells (Figure 6B),
suggesting that through GHSR1a/OX1R heterodimers ghrelin
induces a cAMP-response element signaling, but orexin-A
cannot enhance the cAMP level through the GHSR1a/OX1R
heterodimer.
Detection of Intracellular Calcium
Concentration in HEK293-GHSR1a/OX1R
Cells
Calcium is the downstream second messenger of the Gαq
subtype of the G protein signaling pathway, and the detection
of intracellular calcium facilitates elucidation of the effects
of the GHSR1a/OX1R dimer on the intracellular signal
transduction pathway. The results are shown in Figures 6C,D.
The calcium content in HEK293-OX1R cells (2.8 ± 0.2)
was significantly increased compared with that in the basal
group (0.58 ± 0.08) under the action of orexin-A. The
concentration of calcium in HEK293-GHSR1a cells (2.8 ± 0.05)
was significantly different from that in the empty vector group
(0.54 ± 0.05). In addition, the statistical analyses (Figure 6D)
were performed with SPSS (version 19.0). It was found that
there are differences in different time results, and there are
differences among different groups at different times (20, 80,
and 140 s). The results of the comparison between the two
groups showed that there was a statistical difference between
the basal group and the other three groups (P < 0.01), and
there was a statistical difference between double-transfected
cells group and single-transfected cells group (P = 0.042,
P = 0.017).
However, the calcium levels in HEK293-GHSR1a/OX1R cells
did not differ from those in HEK293-GHSR1a or HEK293-OX1R
cells. Based on these results, the GHSR1a/OX1R dimer is not
associated with the G protein binding of the Gαq subtype, and
the GHSR1a/OX1R dimer alters the signal transduction pathway
of the original monomer.
Identification of a G-protein Coupling to
GHSR1a/OX1R Heterodimers Using
BiFC-BRET
GHSR1a/OX1R heterodimers can exhibit a signaling that is
different from that of their monomers. To survey interactions
between GHSR1a/OX1R heterodimers and Gα, BIFC-BRET
assay were performed (Cai et al., 2017).
As shown in Figure 7, when GHSR1a and OX1R were
co-expressed, changes in the BRET ratio between BiFC
(GHSR1a-VN173 and OX1R-VC155) and Rluc8-tagged Gαq
(Figure 7A), Gαs (Figure 7B), or Gαi2 (Figure 7C) were
observed. In response to corresponding ligands, the expression
of Rluc8-labeled Gαi2 (Rluc8-Gαi2) and BiFC (GHSR1a/OX1R)
in HEK293 cells did not undergo significant changes in terms of
the BRET ratio. In the HEK293-GHSR1a/OX1R cells after agonist
stimulation, the BRET ratio between BiFC (GHSR1a-VN173 and
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FIGURE 6 | Effect of GHSR1a/OX1R heterodimerization on intracellular second messengers. (A) ELISA assay for cAMP. HEK293-GHSR1a, HEK293-OX1R, and
HEK293-GHSR1a/OX1R cells were stimulated with forskolin (10 µM) in the absence or presence of various concentrations of orexin-A (0.001–1000 nM) and/or
ghrelin (0.001–1000 nM). Intracellular cAMP concentrations were measured using an ELISA assay. Values represent the mean ± SEM (N = 3) of three measurements
from three independent experiments. The curve was fitted using nonlinear regression [log (agonist) vs. response – variable slope] in Prism 5.0. (B) BRET EPAC
biosensor for cAMP monitoring. Measurement of BRET signals in HEK293 cells co-expressing the cAMP biosensor and GHSR1a, OX1R, or GHSR1a/OX1R and
stimulated with ghrelin and/or orexin-A. ∗p < 0.05; ∗∗p < 0.01. The data are expressed as the mean ± SEM (N = 3) of four independent experiments.
(C) Intracellular calcium assay. HEK293 cells stably expressing GHSR1a, OX1R, or GHSR1a/OX1R were treated with ghrelin (100 nM) or orexin-A (100 nM). The
fluorescence intensity of intracellular calcium was recorded 20 s after stimulation using a Fluo-4 NW Calcium Assay Kit. Untransfected cells were used as a control.
The results are the mean ± SEM (N = 3) of at least four independent experiments. Statistical analysis was performed using one-way ANOVA followed by Tukey’s
multiple comparison post hoc test. ∗∗∗p < 0.001 vs. basal groups. (D) Time-dependent activation of intracellular calcium by ghrelin or orexin-A in HEK293-GHSR1a,
OX1R, or GHSR1a/OX1R cells. The intracellular calcium concentration was detected as described above. The statistical analyses were performed with SPSS
(version 19.0). It was found that there are differences in different time results, and there are differences among different groups at different times (20, 80, and 140 s).
The results of the comparison between the two groups showed that there was a statistical difference between the basal group and the other three groups
(P < 0.01), and there was a statistical difference between double-transfected cells group and single-transfected cells group (P = 0.042, P = 0.017).
OX1R-VC155) and Rluc8-tagged Gαq was smaller than that
expressing GHSR1a or OX1R alone in cells.
More interestingly, the BRET ratio between BiFC
(GHSR1a-VN173 and OX1R-VC155) and Rluc8-tagged Gαs
showed a significant increase after ghrelin stimulation compared
with that of cells expressing GHSR1a alone. The results indicate
that GHSR1a/OX1R heterodimers activate Gαs but not Gαi2 or
Gαq and that ghrelin induces a Gαs signaling via GHSR1a/OX1R
heterodimers (Figure 7B).
β-arrestin Assay of GHSR1a/OX1R
Heterodimerization
When HEK293 cells expressing β-arrestin1-Rluc8 and BIFC
(GHSR1a-VN173 and OX1R-VC155) were treated with
ghrelin (100 nM) and/or orexin-A (100 nM), a strong and
increasing ligand induced BRET signal was noted, indicating
that β-arrestin1 is raised as a result of activated GHSR1a/OX1R
heterodimers (Figure 8A). Ghrelin or orexin-A treatment of
cells transfected with BIFC and β-arrestin1-Rluc8 increased
BRET value with a reduced magnitude but a similar kinetic
profile. No changes in BRET were observed with the negative
controls (β-arrestin 1-Rluc8 and GHSR1a-VN173, or β-arrestin
1-Rluc8 and OX1R-VC155). However, incubation of HEK293
cells co-expressing GHSR1a/OX1R with ghrelin or and orexin-A
increased BRET value, indicating the proximity of these
heteromeric complexes that recruit β-arrestin1 (Figure 8A).
Similarly, ligand-dependent recruitment of β-arrestin2 was seen
in these heterodimer complexes (Figure 8B). The statistical
analyses (Figures 8A,B) were performed with SPSS (version
19.0). The results of taking time 15, 25, and 35 min to
analyze the results of four measurements show that there
are statistical differences in different times. There was no
significant difference between the control groups (two groups)
and the experimental groups (three groups). The difference
between the control groups and the experimental groups was
statistically significant (P < 0.01). The results indicated that
GHSR1a/OX1R heterodimer does not change recruitment of
β-arrestins.
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FIGURE 7 | Bioluminescence resonance energy transfer analysis of the
effects of GHSR1a/OX1R heterodimerization on Gα protein subunit activation.
HEK293 cells expressing GHSR1a, OX1R or BIFC (GHSR1a/OX1R) were
stimulated with 100 nM ghrelin and/or 100 nM orexin-A for 20 min, and
analysis of the interaction between GHSR1a/OX1R heterodimers and
(A) Gαq-Rluc8, (B) Gαs-Rluc8, and (C) Gαi2-Rluc8 was performed using
BRET. ∗∗p < 0.01, HEK293 cells co-expressing GHSR1a/OX1R stimulated
with ghrelin (100 nM) vs. HEK293 cells expressing GHSR1a only;. The data
points represent the mean ± SEM (N = 3) of four independent experiments.
ns, not significant, as determined by two independent samples t-test.
Ghrelin Enhances SH-SY5Y Cell
Proliferation
In the above experiments, we observed that GHSR1a/OX1R
may heterodimerize. To discuss the GHSR1a/OX1R dimerization
effect on vitality of cells, we examined the GHSR1a/OX1R
heterodimerization effect on cell proliferation. As shown in
Figure 9A, ghrelin had a significant effect on the proliferation
of SH-SY5Y-GHSR1a/OX1R cells, and this functional outcome
of GHSR1a/OX1R co-expression followed a dose-dependent
pattern, reaching significance (p < 0.01) at 100 nM (Figure 9A).
Interestingly, the cell viability of the SH-SY5Y-GHSR1a/OX1R
group was also higher than the SH-SY5Y-GHSR1a group treated
with ghrelin (Figure 9B). These data indicate that activation of
GHSR1a/OX1R heterodimers could increase proliferation of the
SH-SY5Y neuroblastoma cell.
DISCUSSION
GPCRs are well known to exist as monomeric entities that
can form dimers and/or oligomers when expressed in a
heterologous cell system, as well as in native tissues. For example,
human muscarinic M1 receptor is present on the basolateral
surface of cells as a 75:25 mixture of receptor monomers and
dimers/oligomers (Pediani et al., 2016; Bai et al., 2017). The
proportion of APJ monomers, dimers, and oligomers is ∼40%,
∼36%, and ∼24%, respectively (Cai et al., 2017). However, the
proportion of these forms can be regulated by interactions with
ligands, and these effects have major implications for receptor
function and behavior.
GPCR dimerization in vivo and in vitro has been demonstrated
using a range of techniques, including Co-IP, resonance energy
transfer and protein fragment complementation assay (Borroto-
Escuela et al., 2013; Gomes et al., 2016). GHSR1a and OX1R
are found co-expressed in many brain regions such as the
cortex, hypothalamus, pituitary, hippocampus, amygdala, ventral
tegmentum and nucleus raphe. We speculated that receptor
coexpression in the same neurons can lead to interactions
between GHSR1a and OX1R by heterodimers.
Here, BRET, FRET, and BiFC analysis and traditional Co-IP
data provide solid evidence for the formation of functional
GHSR1a/OX1R heterodimers. Additionally, we examined
the interacting interfaces of GHSR1a/OX1R dimers using
interference peptides and BRET. Through the study of interfering
peptides’ effects on interactions between GHSR1a/OX1R, we
discovered that TM5, but not TM1 or TM7, could bind to OX1R,
showing that TM5 is involved in the heterodimer interface
formation. Most likely, two of these form the dimer in the
inactive state. Furthermore, the main dimer interface in the
active state requires further investigation. These findings suggest
that these interfering peptides have therapeutic potential, as
they can disrupt dimerization and influence receptor function.
Indeed, a peptide derived from TM6 of β2-adrenergic receptor
(β2AR) disrupts dimer formation and decreases receptor
function (Chen et al., 2015; Koroglu and Akten, 2015). Thus,
identification of a peptide that interferes with the D1R-D2R
interaction and has antidepressant activity may provide a new
therapeutic strategy for the treatment of major depression (Pei
et al., 2010).
Heteromerization of GPCRs is an important mechanism that
can regulate receptor function. Receptor–receptor interactions
potentially stabilize specific conformations and lead to coupling
with discrete effectors, resulting in heterodimer-specific signal
transduction (Kern et al., 2012; Ferré et al., 2014; Franco
et al., 2016). For example, Chen et al. have showed that
heterodimerization of human OX1R and κOR promotes protein
Frontiers in Molecular Neuroscience | www.frontiersin.org 10 July 2018 | Volume 11 | Article 245
fnmol-11-00245 July 16, 2018 Time: 16:12 # 11
Xue et al. GHSR1a/OX1R Heterodimers Induced Gas Signaling
FIGURE 8 | Characterization of β-arrestin recruitment to GHSR1a/OX1R heterodimers. HEK293 cells transiently co-expressing BIFC
(GHSR1a-VN173/OX1R-VC155) and (A) β-arrestin1-Rluc8 or (B) β-arrestin2-Rluc8 were assessed using BIFC-BRET to generate kinetic curves. Following the
addition of 100 nM ghrelin and/or 100 nM orexin-A, the test continued for 50 min. The data points represent the mean ± SEM (N = 3) of four independent
experiments. The statistical analyses were performed with SPSS (version 19.0). The results of taking time 15, 25, and 35 min to analyze the results of four
measurements show that there are statistical differences in different times. There was no significant difference between the control groups (two groups) and the
experimental groups (three groups). The difference between the control groups and the experimental groups was statistically significant (P < 0.01).
FIGURE 9 | Proliferation of stable cell groups in response to ghrelin. (A) Dose-dependent effects of ghrelin on stable SH-SY5Y-GHSR1a/OX1R cell proliferation. Cell
proliferation was measured using a CCK-8 proliferation/viability assay. Stable cells that were not stimulated with ghrelin were used as the control. ∗∗p < 0.01, cells
co-expressing both GHSR1a/OX1R and treated ghrelin vs. control. (B) The stable SH-SY5Y-GHSR1a, SH-SY5Y-OX1R, and SH-SY5Y-GHSR1a/OX1R cells or
SH-SY5Y cells were cultured in a 96-well plate and starved overnight in serum-free medium. Then, cells were stimulated with 100 nM ghrelin or 100 nM orexin-A or
100 nM ghrelin/orexin-A. Cell proliferation was measured as above. SH-SY5Y cells (Untransfected cells) were used as the control. The data points represent the
mean ± SEM (N = 3) of four independent experiments. ∗∗p < 0.01, cells co-expressing both GHSR1a/OX1R treated with 100 nM ghrelin vs. control.
kinase A and cAMP-response element binding protein signaling
via a Gαs-mediated mechanism (Chen et al., 2015). Jiang et al.
(2006) have shown a molecular mechanism for the synergistic
effect of dopamine receptor D1-GHSR1a dimerization on cAMP
accumulation (Jiang et al., 2006). In the ventral tegmental
area, OX1R and corticotropin-releasing factor (CRF) receptor
heterodimers serve as targets for cocaine and promote long-term
disruption of negative crosstalk between orexin-A and CRF
(Navarro et al., 2015; Bai et al., 2017). Heteromultimerization
of cannabinoid (CB) 1 receptor and OX1R generates a unique
complex, in which both protomers are regulated by orexin-A
(Ward et al., 2011; Bai et al., 2017). Rediger et al. (2009) have
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demonstrated GHSR1a-melanocortin-3 receptor (MC3R) dimers
using FRET. Typical signaling through MC3R involves a Gαs
pathway leading to cAMP accumulation (Rediger et al., 2009).
In the present study, using both BRET and FRET technology,
we confirmed that GHSR1a/OX1R form heterodimers. BRET
analysis also indicated that ghrelin or orexin-A treatment had
little effect on the interaction between GHSR1a/OX1R. To
further study whether heterodimerization leads to signaling
alterations and allosteric signaling, we researched the effects
of GHSR1a/OX1R heterodimerization on G-protein subunit
coupling. Surprisingly, although it has been previously reported
that GHSR1a/OX1R mainly couple with the major Gαq receptors,
we found that the BRET ratio between BiFC (GHSR1a-VN173
and OX1R-VC155) and Rluc8-tagged Gαs was significantly
increased after ghrelin or ghrelin/orexin-A stimulation compared
with that of cells expressing GHSR1a or OX1R alone, suggesting
that Gαs could be activated by the dimer. By contrast,
activation of Gαq and Gαi2 was not found in the cells
expressing GHSR1a/OX1R, which suggests that GHSR1a/OX1R
heterodimerization upregulated Gαs-protein coupling and leads
to a Gαs signaling and asymmetric allosteric signaling.
In recent years, there has been controversy over whether
GPCRs present during physiological function as monomers
(Whorton et al., 2008), dimers (Fung et al., 2009; Han et al.,
2009; Franco et al., 2016), or even larger oligomers (Gurevich
and Gurevich, 2008; Bouvier and Hebert, 2014). An obvious
functional advantage of dimers, which are easier to understand in
heterologous contexts, is that they can interact through allosteric
interactions that may or may not be dependent on ligand
occupancy. In this context, GPCR oligomers can function as
allosteric machines (Kenakin, 2012; Ferré et al., 2014; Moreno
et al., 2016). For example, one ligand-occupied protomer in a
heterodimer can act as an allosteric modulator for the other
protomer, affecting ligand binding and/or signaling conduction
(Muller et al., 2012). The findings of our study are consistent with
this notion. GHSR1a/OX1R heterodimers can induce significant
changes in downstream signaling with ghrelin stimulation,
indicating that heterodimerization of GHSR1a/OX1R is a
complex mechanism regulating receptor function, especially in
asymmetric allosteric and two ligand regulation. The study results
showed that allosteric communication between the dimer could
select the downstream signal pathway.
Furthermore, second messenger concentrations have been
measured. The results show that cAMP accumulation in
double-transfected cells treated with ghrelin or ghrelin/orexin-A
was significantly greater than in single-transfected cells. The
cAMP levels increased in a dose-dependent manner. The results
indicate that GHSR1a/OX1R may strengthen Gαs coupling, when
GHSR1a/OX1R are expressed together. The Ca2+ levels were also
measured after stimulation with ghrelin or orexin-A observed no
significant difference in any of the three cell types. This suggests
that the distinct conformations are mainly caused by receptor
heterodimerization, which increases the activation of Gαs (Chen
et al., 2015).
The effects on the Gαs/Gαq/Gαi signaling pathways of
GHSR1a/OX1R heterodimers were confirmed by detection
of signals downstream from CRE, NFAT-RE and SRE.
The results showed that NFAT-RE and SRE activity in
single-transfected cells was higher than in double-transfected
cells. In double-transfected cells with ghrelin stimulation,
CRE activity was significantly higher than in ghrelin-treated
single-transfected cells, suggesting that CRE activity is induced
via the Gαs/cAMP/cAMP-response element signaling pathway
upon co-expression of the two receptors. The increasing
activity of CRE provide further evidence that dimerization
of GHSR1a/OX1R, when co-expressed, leads to an increase
in Gαs coupling. Taken together, we suggest that allosteric
signaling through GHSR1a/OX1R heterodimers represents a
Gαs/cAMP /cAMP-response element signaling pathway. In this
way, rearrangements of structure can elicit a change in signaling
cascades within GPCR dimers and demonstrate an important
role in structural rearrangements that confirm downstream
signaling is mediated by interaction between GHSR1a and
OX1R. Although it is difficult to transfer the mechanism of
overexpression research in the HEK 293 cells to the endogenous
expression receptor in the cell system and in vivo, the presence
and functional relevance of GPCR dimers or higher oligomers
is usually accepted. GPCRs form dimers in heterologous cells,
resulting in an apparent plethora of functional consequences.
Further research would be to investigate to the physiological
functions for GPCR Dimers in native tissue.
To evaluate whether dimerization of GHSR1a/OX1R affects
cellular functions (for example, cell viability), and to investigate
whether the neuronal cells that coexpress GHSR1a and OX1R
are characterized by cellular functions, we selected the SH-SY5Y
neuroblastoma cell line that generated SH-SY5Y cells that stably
express GHSR1a and OX1R. Cell proliferation was investigated.
After treatment with ghrelin, the proliferation of SH-SY5Y
GHSR1a and OX1R cells was significantly higher than that of
SH-SY5Y GHSR1a or SH-SY5Y OX1R cells alone. Furthermore,
ghrelin induced the proliferation of human SH-SY5Y GHSR1a
and OX1R cells in a dose-dependent manner. These results
indicate that ghrelin plays a role by increasing the proliferation
of SH-SY5Y GHSR1a and OX1R cells.
The results of the present study are consistent with
those of a series of previous experiments indicating that
structural rearrangements of GPCRs can influence cell signaling,
in that ghrelin stimulation of GHSR1a/OX1R heterodimers
induced great changes in downstream signaling, indicating
that herterodimerization of GHSR1a/OX1R is an underlying
mechanism by which receptor function is complex, especially
upon asymmetric allosteric regulation.
CONCLUSION
This study reports that GHSR1a forms heterodimers with
OX1R. We showed that ghrelin stimulation of cells expressing
GHSR1a/OX1R heterodimers led to activation of Gαs
proteins. Stimulation of GHSR1a/OX1R heterodimers with
orexin-A did not alter GPCR interactions with Gα protein
subunits. GHSR1a/OX1R heterodimers induced signaling
pathway activity of Gαs/protein kinase A pathway, including
increasing cAMP-response element luciferase reporter activity
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and cAMP levels. In addition, ghrelin induced a higher
proliferation rate in SH-SY5Y cells than control. This suggest
that ghrelin through GHSR1a/OX1R heterodimers reveals a
Gαs–cAMP-cAMP response element binding protein signaling
in vitro. However, translation of in vitro observations for
GHSR1a/OX1R heterodimer to native tissues is required in the
future to confirm that heterodimers exist in vivo. The roles of
GHSR1a/OX1R heterodimers are needed to further investigate
the physiological functions in vivo experiments, such as using in
situ proximity ligation assay, and time-resolved FRET method.
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